MedPath

Sentrazolpidem PM-5

Zolpidem Tablets, USP Rx only Rev. 06/10 These highlights do not include all the information needed to use ZOLPIDEM TARTRATE TABLETS safely and effectively. See full prescribing information for ZOLPIDEM TARTRATE TABLETS ZOLPIDEM TARTRATE tablet for oral use - CIV Initial U.S. Approval: 1992

Approved
Approval ID

54101870-d8a8-4b35-a31d-93480af9d181

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Aug 1, 2011

Manufacturers
FDA

Physician Therapeutics LLC

DUNS: 931940964

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

ZOLPIDEM TARTRATE, CHOLINE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code68405-023
Product Classification
G
Generic Name
ZOLPIDEM TARTRATE, CHOLINE
Product Specifications
Route of AdministrationORAL
Effective DateAugust 10, 2011
FDA Product Classification

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Sentrazolpidem PM-5 - FDA Drug Approval Details